| The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review G Scaletta, F Plotti, D Luvero, S Capriglione, R Montera, A Miranda, ... Expert review of anticancer therapy 17 (9), 827-839, 2017 | 164 | 2017 |
| The role of novel biomarker HE4 in endometrial cancer: a case control prospective study R Angioli, F Plotti, S Capriglione, R Montera, P Damiani, R Ricciardi, ... Tumor Biology 34, 571-576, 2013 | 147 | 2013 |
| Thyroid physiology and common diseases in pregnancy: review of literature P Cignini, EV Cafà, C Giorlandino, S Capriglione, A Spata, N Dugo Journal of prenatal medicine 6 (4), 64, 2012 | 140 | 2012 |
| Management of endometrial, ovarian and cervical cancer in the elderly: current approach to a challenging condition SG Vitale, S Capriglione, G Zito, S Lopez, FA Gulino, F Di Guardo, ... Archives of gynecology and obstetrics 299, 299-315, 2019 | 133 | 2019 |
| The role of oxidative stress and membrane transport systems during endometriosis: a fresh look at a busy corner SG Vitale, S Capriglione, I Peterlunger, VL La Rosa, A Vitagliano, ... Oxidative medicine and cellular longevity 2018 (1), 7924021, 2018 | 128 | 2018 |
| Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer R Angioli, F Plotti, R Montera, A Aloisi, D Luvero, S Capriglione, ... Gynecologic oncology 127 (2), 290-296, 2012 | 115 | 2012 |
| Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? R Angioli, F Plotti, S Capriglione, A Aloisi, R Montera, D Luvero, ... Gynecologic oncology 128 (3), 579-583, 2013 | 99 | 2013 |
| Does HE4 have a role as biomarker in the recurrence of ovarian cancer? F Plotti, S Capriglione, C Terranova, R Montera, A Aloisi, P Damiani, ... Tumor Biology 33, 2117-2123, 2012 | 93 | 2012 |
| Ten years of HPV vaccines: State of art and controversies R Angioli, S Lopez, A Aloisi, C Terranova, C De Cicco, G Scaletta, ... Critical reviews in oncology/hematology 102, 65-72, 2016 | 81 | 2016 |
| The effects of giving patients verbal or written pre-operative information in gynecologic oncology surgery: a randomized study and the medical-legal point of view R Angioli, F Plotti, S Capriglione, A Aloisi, ME Aloisi, D Luvero, A Miranda, ... European journal of obstetrics & gynecology and reproductive biology 177, 67-71, 2014 | 79 | 2014 |
| Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature S Capriglione, D Luvero, F Plotti, C Terranova, R Montera, G Scaletta, ... Medical Oncology 34, 1-5, 2017 | 74 | 2017 |
| A critical review on HE4 performance in endometrial cancer: where are we now? R Angioli, A Miranda, A Aloisi, R Montera, S Capriglione, ... Tumor Biology 35, 881-887, 2014 | 66 | 2014 |
| Ovarian cancer relapse: from the latest scientific evidence to the best practice D Luvero, F Plotti, A Aloisia, R Montera, C Terranova, CDC Nardone, ... Critical reviews in oncology/hematology 140, 28-38, 2019 | 63 | 2019 |
| Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? R Angioli, S Capriglione, A Aloisi, F Guzzo, D Luvero, A Miranda, ... Tumor Biology 35, 7009-7015, 2014 | 63 | 2014 |
| Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors F Plotti, C Terranova, S Capriglione, S Crispino, AL Pomi, ... International Journal of Gynecologic Cancer 28 (4), 2018 | 53 | 2018 |
| Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study S Capriglione, F Plotti, A Miranda, R Ricciardi, G Scaletta, A Aloisi, ... Tumor Biology 36, 4151-4156, 2015 | 50 | 2015 |
| Fertility outcome after laparoscopic salpingostomy or salpingectomy for tubal ectopic pregnancy. A 12-years retrospective cohort study AS Laganà, SG Vitale, R De Dominici, F Padula, AMC Rapisarda, ... Annali italiani di chirurgia 87 (5), 461-465, 2016 | 46 | 2016 |
| The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program R Angioli, S Capriglione, G Scaletta, A Aloisi, A Miranda, ... Tumor Biology 37, 4973-4978, 2016 | 46 | 2016 |
| Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study R Angioli, F Plotti, D Luvero, A Aloisi, F Guzzo, S Capriglione, ... Tumor Biology 35, 2741-2746, 2014 | 41 | 2014 |
| Economic impact among family caregivers of patients with advanced ovarian cancer R Angioli, S Capriglione, A Aloisi, A Miranda, C de Cicco Nardone, ... International Journal of Gynecologic Cancer 25 (8), 2015 | 40 | 2015 |
